Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

USD 18.51

(5.05%)

Gross Profit Summary of Biohaven Pharmaceutical Holding Company Ltd.

  • Biohaven Pharmaceutical Holding Company Ltd.'s latest annual gross profit in 2023 was -3.36 Million USD , down -143.07% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd.'s latest quarterly gross profit in 2024 Q2 was -977 Thousand USD , down -3.83% from previous quarter.
  • Biohaven Pharmaceutical Holding Company Ltd. reported a annual gross profit of -1.38 Million USD in annual gross profit 2022, down -100.37% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd. reported a annual gross profit of 370.84 Million USD in annual gross profit 2021, up 515162.5% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd. reported a quarterly gross profit of -941 Thousand USD for 2024 Q1, up 0.74% from previous quarter.
  • Biohaven Pharmaceutical Holding Company Ltd. reported a quarterly gross profit of -800 Thousand USD for 2023 Q2, down -4.71% from previous quarter.

Annual Gross Profit Chart of Biohaven Pharmaceutical Holding Company Ltd. (2023 - 2017)

Historical Annual Gross Profit of Biohaven Pharmaceutical Holding Company Ltd. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 -3.36 Million USD -143.07%
2022 -1.38 Million USD -100.37%
2021 370.84 Million USD 515162.5%
2020 -72 Thousand USD 0.0%
2019 - USD 0.0%
2017 - USD 0.0%

Peer Gross Profit Comparison of Biohaven Pharmaceutical Holding Company Ltd.

Name Gross Profit Gross Profit Difference
ADC Therapeutics SA 67.02 Million USD 105.026%
Alto Neuroscience, Inc. -373 Thousand USD -803.217%
Annovis Bio, Inc. - USD Infinity%
Ginkgo Bioworks Holdings, Inc. 197.45 Million USD 101.706%
Nuvation Bio Inc. -222 Thousand USD -1417.568%
Nuvation Bio Inc. -222 Thousand USD -1417.568%
Arcus Biosciences, Inc. -223 Million USD 98.489%
Zymeworks Inc. -66.97 Million USD 94.97%